Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension

L. Savale, J. Le Pavec, O. Mercier, S. Mussot, D. Fabre, X. Jais, D. Montani, O. Sitbon, M. Humbert, G. Simonneau, P. Dartevelle, E. Fadel (Le Kremlin Bicêtre, Le Plessis Robinson, France)

Source: International Congress 2014 – Pulmonary hypertension: clinical management
Session: Pulmonary hypertension: clinical management
Session type: Thematic Poster Session
Number: 2372
Disease area: Pulmonary vascular diseases, Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Savale, J. Le Pavec, O. Mercier, S. Mussot, D. Fabre, X. Jais, D. Montani, O. Sitbon, M. Humbert, G. Simonneau, P. Dartevelle, E. Fadel (Le Kremlin Bicêtre, Le Plessis Robinson, France). Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension. Eur Respir J 2014; 44: Suppl. 58, 2372

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary hemodynamics and lung function in patients with COPD and DPLD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Improving the safety of right heart catheterisation in sickle cell disease
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Effect of pulmonary hemodynamics on the prognosis of patients with emphysematous COPD after LVRS
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Long-term screening for pulmonary hypertension after pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Pulmonary arterial hypertension – A single-centre experience
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Non-invasive cardiac output assessment in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Impact of sepsis in respiratory mechanics of pulmonary arterial hypertension rat model. Preliminary results
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Nebivolol and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014